$285.75
Value $689B
Johnson & JohnsonvsBio-Techne
JNJ and TECH stock compared: price, dividend, valuation and results, from SEC filings.
+0.79%
$72.80
Value $11.4B
Johnson & Johnson (JNJ) has a market value of $689B and Bio-Techne (TECH) $11.4B. Over the last year, with dividends, JNJ moved +50.3% and TECH +19.4%. The P/E is 42.8 for JNJ and 66.5 for TECH. Dividend yield: JNJ 1.85%, TECH 0.44%.
At a glance
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
JNJ$689B
TECH$11.4B
JNJ is 60 times TECH
Revenue, 12 months
JNJ$99.3B
TECH$1.2B
JNJ is 81 times TECH
Net income, 12 months
JNJ$16.1B
TECH$172M
JNJ is 94 times TECH
Operating margin
JNJ–
TECH19.6%
ROIC
JNJ12.4%
TECH7.7%
4.7 points apart
P/E
JNJ42.8
TECH66.5
TECH is 1.6 times JNJ
Dividend yield
JNJ1.8%
TECH0.4%
1.5 points apart
5-year return
JNJ+99.1%
TECH-40.9%
140.0 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
The price over time
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
JNJ+99.1%
TECH-40.9%
| Period | JNJWith dividends | TECHWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +50.3%Price +47.0% | +19.4%Price +18.6% |
| 3 years since November 13, 2023 | +110.8%+28.2% a yearPrice +93.6% | +29.5%+9.0% a yearPrice +27.5% |
| 5 years since November 12, 2021 | +99.1%+14.8% a yearPrice +73.2% | -40.9%-10.0% a yearPrice -42.3% |
| 10 years since November 15, 2016 | +222.3%+12.4% a yearPrice +145.7% | +190.5%+11.3% a yearPrice +174.4% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
Every figure
As on each company's page. A description, not a recommendation: no one figure says which is better.
JNJJohnson & JohnsonTECHBio-Techne
Valuation
JNJTECH| Price | $285.75 | $72.80 |
|---|---|---|
| Market value | $689B | $11.4B |
| Enterprise value (EV) | $716B | $11.5B |
| P/E | 42.8 | 66.5 |
| P/E, 5-year median | 21.9 | 56.6 |
| P/B | 8.5 | 5.3 |
| EV/EBIT | 40.4 | 47.7 |
| Free cash flow yield | 3.0% | 2.7% |
Results and growth
JNJTECH| Revenue, 12 months | $99.3B | $1.2B |
|---|---|---|
| Net income, 12 months | $16.1B | $172M |
| Free cash flow, 12 months | $20.6B | $308M |
| Earnings per share, 12 months | $6.59 | $1.09 |
| Revenue growth, year on year | 6.1% | -0.4% |
| Revenue growth a year, past | +2.7%over 5 years | +5.5%over 5 years |
| EPS growth a year, past | +14.9%over 5 years | +5.9%over 5 years |
Margins and returns on capital
JNJTECH| Gross margin | 67.6% | 65.8% |
|---|---|---|
| Operating margin | – | 19.6% |
| Net margin | 16.2% | 14.0% |
| ROIC | 12.4% | 7.7% |
| ROE | 19.7% | 8.3% |
Balance sheet
JNJTECH| Cash | $17.2B | $350M |
|---|---|---|
| Total debt | $44.7B | $486M |
| Net debt / EBITDA | 1.1 | 0.2 |
| Interest cover | 18.0× | 27.2× |
Dividends and buybacks
JNJTECH| Dividend yield | 1.8% | 0.4% |
|---|---|---|
| Dividend per share, 12 months | $5.28 | $0.32 |
| Dividend growth a year, past | +5.3%over 5 years | +0.0%over 5 years |
| Buyback yield | 0.9% | 0.4% |
| Shareholder yield | 2.7% | 0.8% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
Which is bigger, Johnson & Johnson or Bio-Techne?
By market value, Johnson & Johnson ($689B) is about 60.2 times Bio-Techne ($11.4B), at today's prices.
How did JNJ and TECH stock do over the last 10 years?
Since November 15, 2016, JNJ's price moved +145.7% and TECH's +174.4%. With dividends: JNJ +222.3% (+12.4% a year), TECH +190.5% (+11.3% a year). Past returns do not predict future ones.
Which pays the higher dividend, JNJ or TECH?
The dividend yield at today's price is 1.85% for Johnson & Johnson and 0.44% for Bio-Techne. Over the last twelve months they paid $5.28 and $0.32 per share.
What is the P/E of JNJ and TECH?
At today's price, the P/E is 42.8 for JNJ and 66.5 for TECH. The median of the last five years was 21.9 and 56.6, which shows where each stands against its own past.
Which has the higher profit margins, Johnson & Johnson or Bio-Techne?
Over the last twelve months, the net margin was 16.2% for Johnson & Johnson and 14.0% for Bio-Techne, and the operating margin – and 19.6%. Revenue was $99.3B and $1.2B.
Which is the better investment, Johnson & Johnson or Bio-Techne?
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
Other comparisons
With each of the two, and with the largest in its sector.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.
Descriptive data from SEC filings and market prices.